- Home
- ICUI vs TGS Comparison
ICUI vs TGS Comparison
Compare ICUI & TGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- TGS
- Stock Information
- Founded
- ICUI 1984
- TGS 1992
- Country
- ICUI United States
- TGS Argentina
- Employees
- ICUI N/A
- TGS N/A
- Industry
- ICUI Medical/Dental Instruments
- TGS Natural Gas Distribution
- Sector
- ICUI Health Care
- TGS Utilities
- Exchange
- ICUI Nasdaq
- TGS Nasdaq
- Market Cap
- ICUI 3.6B
- TGS 4.1B
- IPO Year
- ICUI 1992
- TGS N/A
- Fundamental
- Price
- ICUI $138.67
- TGS $27.40
- Analyst Decision
- ICUI Buy
- TGS Strong Buy
- Analyst Count
- ICUI 4
- TGS 1
- Target Price
- ICUI $199.67
- TGS $35.00
- AVG Volume (30 Days)
- ICUI 339.0K
- TGS 313.5K
- Earning Date
- ICUI 05-06-2025
- TGS 05-05-2025
- Dividend Yield
- ICUI N/A
- TGS N/A
- EPS Growth
- ICUI N/A
- TGS 622.80
- EPS
- ICUI N/A
- TGS 0.48
- Revenue
- ICUI $2,382,046,000.00
- TGS $1,183,090,354.00
- Revenue This Year
- ICUI $0.84
- TGS N/A
- Revenue Next Year
- ICUI $2.91
- TGS N/A
- P/E Ratio
- ICUI N/A
- TGS $11.32
- Revenue Growth
- ICUI 5.44
- TGS 23.70
- 52 Week Low
- ICUI $93.36
- TGS $14.16
- 52 Week High
- ICUI $196.26
- TGS $34.37
- Technical
- Relative Strength Index (RSI)
- ICUI 45.36
- TGS 54.99
- Support Level
- ICUI $136.61
- TGS $26.63
- Resistance Level
- ICUI $145.82
- TGS $30.41
- Average True Range (ATR)
- ICUI 10.06
- TGS 1.83
- MACD
- ICUI 0.10
- TGS 0.32
- Stochastic Oscillator
- ICUI 38.37
- TGS 70.14
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, and Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.